Shepherd says that women who visit the hospital with a suspicious ovarian finding will undergo the standard diagnostic ...

BME PhD student will study point-of-care diagnostics, including how they can account for biomarkers and variations specific ...

ACT: At this year’s SCRS Summit, several site representatives raised concerns about overly complex protocols and patient ...

Understand how combining proprietary and real-world datasets with tokenization enables accurate protocol matching while ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that clinical results from its Phase 1 MYE Symphony trial ...